Presentations

Clinical Pharmacology During Pregnancy: Addressing Clinical Needs Through Science
December 4-5, 2000

Transcripts

• December 4, 2000

• December 5, 2000

Presentations 

1. Addressing Clinical Needs Through Science, Sandra L. Kweder, M.D. FDA, Office of Drug Evaluation IV (Posted 1/31/2001)

2. Closing the Gap in Health Care, Agency for Healthcare Research and Quality (Posted 1/31/2001)

3. Complications with the Use of Anticonvulsants in Pregnancy, Mark Yerby, M.D. M.P.H. (Posted 1/31/2001)

4. Effect of Asthma on Pregnancy, Robert S. Zeiger, MD, PhD (Posted 1/31/2001)

5. Industry Experience: Design & Conduct of a Pregnancy PK Study, Catherine Stika, MD Assistant Professor, Obstetrics &  Gynecology Northwestern University Medical School (Posted 1/31/2001)

6. Interface of Clinical Pharmacology & Drug Safety, Gideon Koren, MD (Posted 1/31/2001)

7. Labeling Products for Use in Pregnancy: Moving Forward, Sandra L. Kweder, M.D. FDA, Office of Drug Evaluation IV (Posted 1/31/2001)

8. Legal Aspects of Studying Pregnant Women, Ellen Wright Clayton (Posted 1/31/2001)

9. Management of Chronic Hypertension During Pregnancy, San Antonio Evidence-Based Center (Posted 1/31/2001)

10. March of Dimes Mission, Nancy Green (Posted 1/31/2001)

11. PhRMA Perspective on Clinical Pharmacology Research in Pregnant Women, Maria Palmisano, MD Director, Clinical Pharmacology/Experimental Medicine, Bristol-Myers Squibb (Posted 1/31/2001) 

12. Physiologic Changes In Pregnancy: Effect on Drug Disposition, Marilynn Frederiksen (Posted 1/31/2001)

13. Psychopharmacology during Pregnancy Addressing Clinical Need through Science, Katherine L. Wisner, M.D., M.S. Professor of Psychiatry and Reproductive Biology, Case Western Reserve University (Posted 1/31/2001)

14. Research Recommendations from the NICHD Workshop on the Need to Study Drugs During Pregnancy, Raymond L. Woosley, MD, PhD, President, American Society for Clinical Pharmacology and Therapeutics (Posted 1/31/2001)